Notably, pharmacological inhibition of valosin containing protein (VCP) or depleting Derlin‐1 in mice reduces TMEM63A‐mediated triple negative breast cancer progression and metastasis (Zhang et al. 2022). The gene discussed is VCP; the disease is triple-negative breast carcinoma.